Jin Medical International (ZJYL) Raw Materials (2022 - 2025)

Jin Medical International (ZJYL) has reported Raw Materials for 4 consecutive years, with $2.1 million the latest figure, recorded in Q3 2025.

• Quarterly Raw Materials rose 1.76% year-over-year to $2.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.1 million (up 1.76% YoY) and the FY2025 annual result came in at $2.1 million, up 1.76% from the prior year.
• Raw Materials steadied at $2.1 million in Q3 2025 per ZJYL's latest filing, from $2.1 million in the prior quarter.
• Over the last five years, Raw Materials for ZJYL reached as high as $3.3 million in Q3 2022 and fell as low as $2.1 million in Q3 2024.
• A 4-year average of $2.5 million and a median of $2.4 million in 2024 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2024 — Raw Materials dropped 21.31% — and 2025, when it climbed 1.76%.
• Year by year, Raw Materials stood at $3.3 million in 2022, then retreated by 20.04% to $2.6 million in 2023, then slipped by 21.31% to $2.1 million in 2024, then climbed by 1.76% to $2.1 million in 2025.
• According to Business Quant data, Raw Materials over the past three periods registered $2.1 million, $2.1 million, and $2.1 million for Q3 2025, Q1 2025, and Q3 2024 respectively.